Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 4, 2022 SEC SCHEDULE 13G
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
4 Feb 3, 2022 FORM 4 SUBMISSION
SC 13G/A Jan 28, 2022 SC 13G/A
4 Jan 3, 2022 FORM 4 SUBMISSION
4 Dec 10, 2021 FORM 4 SUBMISSION
EFFECT Nov 17, 2021
CORRESP Nov 15, 2021
UPLOAD Nov 10, 2021
8-K Nov 8, 2021 8-K
S-3 Nov 8, 2021 S-3
10-Q Nov 5, 2021 10-Q
8-K Nov 4, 2021 8-K
SC 13G Oct 28, 2021
SC 13G Oct 14, 2021 SC 13G
SC 13G/A Oct 8, 2021 SEC SCHEDULE 13G
3 Oct 4, 2021 FORM 3 SUBMISSION
SC 13G Sep 30, 2021 SCHEDULE 13G
SC 13G/A Sep 29, 2021
SC 13G/A Sep 29, 2021 AMENDMENT NO. 2
4 Sep 28, 2021 FORM 4 SUBMISSION
SC 13G Sep 24, 2021
SC 13G/A Sep 24, 2021 AMENDMENT NO. 1
← Newer Page 13 of 33 · 817 filings Older →